Literature DB >> 11263943

Vacuum-assisted closure for cutaneous gastrointestinal fistula management.

A A Alvarez1, G L Maxwell, G C Rodriguez.   

Abstract

BACKGROUND: Cutaneous gastrointestinal (GI) fistulas are a challenging complication in the oncologic patient population. The fistulous effluent is difficult to manage and adversely alters quality of life. Nonsurgical management of enteric fistulas is successful in 30% of cases, requiring at least 4 to 6 weeks. Recently a new technology has been developed to expedite wound healing. The Vacuum-Assisted Closure (VAC) method is a subatmospheric pressure technique that has been demonstrated in laboratory and clinical studies to significantly improve wound healing. Here we report its use in the successful medical management of a cutaneous GI fistula. CASE: A 63-year-old woman with advanced ovarian cancer developed an extensive complex cutaneous GI fistula in an open healing wound. She was treated with total parental nutrition and the VAC device, which resulted in complete closure of the fistula.
CONCLUSION: We propose that the VAC device may be a useful adjunct for the medical management of cutaneous GI fistulas. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11263943     DOI: 10.1006/gyno.2000.6092

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  9 in total

Review 1.  Current management of enterocutaneous fistula.

Authors:  Amy R Evenson; Josef E Fischer
Journal:  J Gastrointest Surg       Date:  2006-03       Impact factor: 3.452

Review 2.  Topical negative pressure therapy: mechanisms and indications.

Authors:  Paul E Banwell; Melinda Musgrave
Journal:  Int Wound J       Date:  2004-06       Impact factor: 3.315

Review 3.  Management of enteroatmospheric fistulae.

Authors:  Cem Terzi; Tufan Egeli; Aras E Canda; Naciye C Arslan
Journal:  Int Wound J       Date:  2014-06       Impact factor: 3.315

Review 4.  Topical negative pressure wound therapy: a review of its role and guidelines for its use in the management of acute wounds.

Authors:  Estas Bovill; Paul E Banwell; Luc Teot; Elof Eriksson; Colin Song; Jim Mahoney; Ronny Gustafsson; Raymund Horch; Anand Deva; Ian Whitworth
Journal:  Int Wound J       Date:  2008-09-19       Impact factor: 3.315

Review 5.  Biliogastric diversion for the management of high-output duodenal fistula: report of two cases and literature review.

Authors:  Konstantinos Milias; Nikolaos Deligiannidis; Theodossis S Papavramidis; Konstantinos Ioannidis; Nikolaos Xiros; Spiros Papavramidis
Journal:  J Gastrointest Surg       Date:  2008-09-30       Impact factor: 3.452

Review 6.  V.A.C. Therapy in the management of paediatric wounds: clinical review and experience.

Authors:  Mona Baharestani; Ibrahim Amjad; Kim Bookout; Tatjana Fleck; Allen Gabriel; David Kaufman; Shannon Stone McCord; Donald C Moores; Oluyinka O Olutoye; Jorge D Salazar; David H Song; Steven Teich; Subhas Gupta
Journal:  Int Wound J       Date:  2009-08       Impact factor: 3.315

7.  Infliximab as a therapy for non-Crohn's enterocutaneous fistulae.

Authors:  Ravindra S Date; Kanwar Jit Singh Panesar; Paul Neilly
Journal:  Int J Colorectal Dis       Date:  2004-06-03       Impact factor: 2.571

8.  Chinese Trauma Surgeon Association for management guidelines of vacuum sealing drainage application in abdominal surgeries-Update and systematic review.

Authors:  Yang Li; Pei-Yuan Li; Shi-Jing Sun; Yuan-Zhang Yao; Zhan-Fei Li; Tao Liu; Fan Yang; Lian-Yang Zhang; Xiang-Jun Bai; Jing-Shan Huo; Wu-Bing He; Jun Ouyang; Lei Peng; Ping Hu; Yan-An Zhu; Ping Jin; Qi-Feng Shao; Yan-Feng Wang; Rui-Wu Dai; Pei-Yang Hu; Hai-Ming Chen; Ge-Fei Wang; Yong-Gao Wang; Hong-Xu Jin; Chang-Ju Zhu; Qi-Yong Zhang; Biao Shao; Xi-Guang Sang; Chang-Lin Yin
Journal:  Chin J Traumatol       Date:  2019-02-14

9.  Internal vacuum-assisted closure device in the swine model of severe liver injury.

Authors:  Christopher B Everett; Bruce W Thomas; Michael Moncure
Journal:  World J Emerg Surg       Date:  2012-12-05       Impact factor: 5.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.